John L. Lamattina, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 4,591 shares at $247.22 ($1.2M) on 2026-06-10, disclosed to the SEC on 2026-06-12.
Seasonal sale ($1.2M) by Director — this insider has traded LGND in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $247.22 | 257 | $64K | 5.5% |
| 2 | $248.11 | 232 | $58K | 5.0% |
| 3 | $249.53 | 697 | $174K | 15.1% |
| 4 | $251.62 | 3,405 | $857K | 74.4% |
| Total | $250.88 avg | 4,591 | $1.2M | 100% |
| Filing → |
| LGND | SELL | 2024-12-02 | $595K | — | Filing → |
| LGND | SELL | 2021-11-17 | $1.6M | — | Filing → |
| IMNM | BUY | 2021-05-26 | $196K | — | Filing → |